{"id":13,"date":"2026-03-04T10:18:32","date_gmt":"2026-03-04T10:18:32","guid":{"rendered":"https:\/\/medi-first-research.de\/?page_id=13"},"modified":"2026-03-18T10:19:01","modified_gmt":"2026-03-18T10:19:01","slug":"forschungsplattform","status":"publish","type":"page","link":"https:\/\/medi-first-research.de\/en\/forschungsplattform\/","title":{"rendered":"Research Platform"},"content":{"rendered":"
<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t

Research Platform<\/h1>\n<\/div>\n\n\n\n

Medi First R&D combines genetics, formulation science, and drug-delivery approaches into an integrated development process - starting from\u00a0Target Product Profiles (TPP)<\/strong>\u00a0and clinical requirements.<\/p>\n

In phytomedicine, a gap still exists between therapeutic potential and robust, comparable evidence. Divergent product profiles and inconsistent dosing logics make clinical decisions difficult. Our research addresses these bottlenecks through standardization, formulation development, and defined evidence pathways.<\/p>\n<\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n\n\t

\n\t\t
<\/div><\/div><\/div>\n\t\t\t
\n\t\t\t\t
<\/div><\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t
<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t

Scientific foundation<\/h2>\n<\/div>\n\n\n\n\n
\n\t

Cannabinoid-based therapies require a clear classification within pharmacology, the endocannabinoid system (ECS), and formulation science. Our focus is on profiles that can be standardized, dosed, and clinically evaluated. You are welcome to request details on methodology, criteria catalogues, and development logic.<\/p>\n<\/div>\n\n\n\n

<\/div><\/div>Get in touch now<\/span><\/a>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t
<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
<\/div> <\/div>
\n\t
\n\t\t
<\/div><\/div>\n\t\t
\n\t\t\t
\n
\n
\n
\n \"\"\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>

Genetics & Chemovar Design<\/h3>\n<\/div>\n
\n\t

The selection and characterization of defined profiles serve as the starting point for standardized active-ingredient and full-spectrum approaches.<\/p>\n<\/div>\n\n\n\n

Focus<\/strong><\/p>\n<\/div>

\n